Introduction

Epistora Journal of Clinical and Translational Medicine (EJCTM) is a premier peer-reviewed, open access journal dedicated to bridging the critical gap between laboratory research and clinical practice. Established to accelerate the translation of scientific discoveries into tangible patient benefits, EJCTM serves as a global platform for translational researchers, clinicians and biomedical scientists to disseminate transformative research

The journal embraces the full spectrum of translational medicine — from bench research and biomarker discovery to clinical trials, drug development and healthcare implementation. With a rigorous double-blind peer review process and rapid publication workflow, we ensure that high-impact translational research reaches the clinical community without delay. All articles are published under the CC BY 4.0 license, enabling unrestricted access, reuse and maximum patient impact

Our commitment extends beyond traditional publishing. We actively promote interdisciplinary collaboration, translational innovation and evidence-based clinical application. By combining scholarly excellence with modern publishing innovations — including audio article summaries and digital preservation — EJCTM is shaping the future of clinical and translational medicine communication

Aim & Scope

Aim: To accelerate the translation of scientific discoveries into clinical applications by publishing high-quality, rigorously peer-reviewed research across all domains of translational medicine. We aim to foster interdisciplinary dialogue, support bench-to-bedside innovation and provide an inclusive open access home for transformative translational science

Scope: The journal welcomes original research articles, comprehensive reviews, short communications, clinical trial reports, and perspectives covering, but not limited to:

Translational Research Immunotherapy Precision Medicine Clinical Trials Biomarker Discovery Drug Development Molecular Diagnostics Pharmacogenomics Targeted Therapy Cell and Gene Therapy Personalized Medicine Bioinformatics Clinical Genomics Proteomics Metabolomics Medical Devices Regenerative Medicine Digital Health AI in Medicine Implementation Science Patient-reported Outcomes Biomarker-based Therapeutics Rare Disease Research Health Economics

Article Types

  • Original Research - Full-length translational studies, biomarker validation, and clinical trial reports. Up to 8,000 words with comprehensive methodology and translational impact assessment
  • Review Articles - Systematic reviews, meta-analyses and comprehensive surveys with translational implications. Up to 6,000 words
  • Short Communications - Urgent translational findings, preliminary biomarker data and time-sensitive discoveries requiring rapid dissemination. Up to 2,500 words
  • Clinical Trial Reports - Detailed reporting of clinical trial design, interim results and translational outcomes with patient data
  • Translational Perspectives - Expert viewpoints on emerging technologies, regulatory challenges and future directions in translational medicine
  • Data Papers - Comprehensive description of high-quality datasets, including clinical trial data and biomarker databases for the translational research community

Mission & Values

Accelerate bench-to-bedside innovation through trusted open access. Core principles: scientific rigour, translational relevance, constructive peer review, rapid decisions, global accessibility without financial barriers. Bridging laboratory science with clinical practice — immunotherapy breakthroughs, precision medicine, biomarker discovery and equitable healthcare delivery

Indexing & Archiving

Google Scholar Research Gate CrossRef DOI ISSN Academia R Discovery

Published content is maintained through structured digital preservation and accessibility practices designed to support long-term scholarly availability and continued research access